Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1619) 1619
Book Review (484) 484
Publication (105) 105
Newsletter (48) 48
Book Chapter (13) 13
Book / eBook (7) 7
Conference Proceeding (3) 3
Magazine Article (3) 3
Newspaper Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1345) 1345
humans (1305) 1305
male (604) 604
female (537) 537
allergic bronchopulmonary aspergillosis (483) 483
aspergillosis, allergic bronchopulmonary - drug therapy (471) 471
adult (428) 428
aspergillosis (409) 409
antifungal agents - therapeutic use (385) 385
middle aged (373) 373
respiratory system (300) 300
pulmonary aspergillosis (280) 280
asthma (262) 262
cystic fibrosis (259) 259
aspergillosis, allergic bronchopulmonary - diagnosis (257) 257
diagnosis (245) 245
itraconazole (244) 244
abridged index medicus (238) 238
immunology (232) 232
aged (222) 222
infectious diseases (207) 207
allergy (200) 200
aspergillosis - drug therapy (196) 196
aspergillus fumigatus (192) 192
aspergillosis, allergic bronchopulmonary - complications (189) 189
aspergillus (189) 189
adolescent (182) 182
invasive aspergillosis (182) 182
child (177) 177
microbiology (177) 177
animals (164) 164
treatment outcome (161) 161
mycoses (159) 159
voriconazole (145) 145
cystic fibrosis - complications (144) 144
care and treatment (137) 137
diagnosis, differential (136) 136
risk factors (134) 134
health aspects (130) 130
aspergillosis - diagnosis (126) 126
aspergillosis, allergic bronchopulmonary - immunology (124) 124
itraconazole - therapeutic use (124) 124
antifungal agents (123) 123
fumigatus (122) 122
mycology (122) 122
fungi (121) 121
tomography, x-ray computed (121) 121
disease (119) 119
therapy (110) 110
infections (108) 108
aspergillus fumigatus - immunology (107) 107
aspergillus fumigatus - isolation & purification (107) 107
research (107) 107
invasive pulmonary aspergillosis (105) 105
patients (105) 105
amphotericin b - therapeutic use (104) 104
aspergillosis - microbiology (101) 101
drug therapy (101) 101
pharmacology & pharmacy (101) 101
asthma - drug therapy (100) 100
cystic-fibrosis (100) 100
antifungal agents - administration & dosage (99) 99
fungal-infections (95) 95
internal medicine (94) 94
medicine, general & internal (94) 94
retrospective studies (93) 93
asthma - complications (90) 90
lung diseases (88) 88
adrenal cortex hormones - therapeutic use (86) 86
infection (84) 84
epidemiology (83) 83
immunocompromised host (83) 83
immunoglobulin e (83) 83
aspergillosis, allergic bronchopulmonary - etiology (82) 82
aspergillosis, allergic bronchopulmonary - microbiology (82) 82
lung diseases, fungal - drug therapy (82) 82
mice (80) 80
chronic disease (79) 79
pediatrics (79) 79
management (77) 77
lung (76) 76
mortality (76) 76
radiography (76) 76
amphotericin b (74) 74
children (74) 74
amphotericin-b (73) 73
aspergillus fumigatus - drug effects (73) 73
medicine & public health (73) 73
immunoglobulin e - blood (72) 72
pneumonia (72) 72
antifungal agents - pharmacology (71) 71
aspergillosis, allergic bronchopulmonary - diagnostic imaging (71) 71
prevalence (71) 71
aspergillosis - immunology (70) 70
lung - pathology (70) 70
corticosteroids (69) 69
inflammation (69) 69
omalizumab (69) 69
young adult (69) 69
aspergillus - isolation & purification (68) 68
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1538) 1538
French (49) 49
Japanese (30) 30
German (24) 24
Spanish (14) 14
Italian (7) 7
Russian (7) 7
Chinese (5) 5
Danish (4) 4
Polish (4) 4
Dutch (3) 3
Turkish (3) 3
Finnish (2) 2
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
by Thomas J. Walsh and Elias J. Anaissie and David W. Denning and Raoul Herbrecht and Dimitrios P. Kontoyiannis and Kieren A. Marr and Vicki A. Morrison and Brahm H. Segal and William J. Steinbach and David A. Stevens and Jo-Anne van Burik and John R. Wingard and Thomas F. Patterson and Infectious Diseases Society of America
Clinical Infectious Diseases, ISSN 1058-4838, 2/2008, Volume 46, Issue 3, pp. 327 - 360
Antifungals | Aspergillus | Invasive pulmonary aspergillosis | Medical treatment | Aspergillosis | Central nervous system | IDSA Guidelines | Infections | Fungal infections | Dosage | Allergic bronchopulmonary aspergillosis | INFECTIOUS DISEASES | LINKED-IMMUNOSORBENT-ASSAY | CHRONIC GRANULOMATOUS-DISEASE | BONE-MARROW-TRANSPLANTATION | MICROBIOLOGY | IMMUNOLOGY | CELL TRANSPLANT RECIPIENTS | INVASIVE PULMONARY ASPERGILLOSIS | POLYMERASE-CHAIN-REACTION | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | CENTRAL-NERVOUS-SYSTEM | LIPOSOMAL-AMPHOTERICIN-B | PRIMARY CUTANEOUS ASPERGILLOSIS | Aspergillosis - therapy | Aspergillosis, Allergic Bronchopulmonary - microbiology | Aspergillosis, Allergic Bronchopulmonary - therapy | Humans | Aspergillosis - microbiology | Lung Diseases, Fungal - drug therapy | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Lung Diseases, Fungal - microbiology | Lung Diseases, Fungal - therapy | Antifungal Agents - therapeutic use | Aspergillosis - drug therapy | Practice guidelines (Medicine) | Evaluation | Care and treatment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Pulmonary infection caused by Nocardia cyriacigeorgica in a patient with allergic bronchopulmonary aspergillosis: A case report
by Wu, Jianyong and Wu, Yingping and Zhu, Zhiqiang
Medicine, ISSN 0025-7974, 10/2018, Volume 97, Issue 43, pp. e13023 - e13023
Rationale: Nocardia species is known as conditional pathogenic bacteria. Among Nocardia species, pulmonary infection caused by Nocardia cyriacigeorgica... 
MEDICINE, GENERAL & INTERNAL | pulmonary infection | SUSCEPTIBILITY | JAPAN | 16S rRNA gene sequencing | allergic bronchopulmonary aspergillosis | Nocardia cyriacigeorgica | Diagnosis, Differential | Nocardia | Humans | Middle Aged | Nocardia Infections - diagnosis | Aspergillosis, Allergic Bronchopulmonary - complications | Female | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Nocardia Infections - complications | Nocardia Infections - drug therapy | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Allergic bronchopulmonary aspergillosis and omalizumab
by Tillie‐Leblond, I and Germaud, P and Leroyer, C and Tétu, L and Girard, F and Devouassoux, G and Grignet, J.‐P and Prudhomme, A and Dusser, D and Wallaert, B
Allergy, ISSN 0105-4538, 09/2011, Volume 66, Issue 9, pp. 1254 - 1256
allergic bronchopulmonary | asthma | aspergillus | ALLERGY | IMMUNOLOGY | ANTI-IGE ANTIBODY | ABPA | Anti-Asthmatic Agents - adverse effects | Antibodies, Anti-Idiotypic - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Omalizumab | Aspergillosis, Allergic Bronchopulmonary - physiopathology | Male | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Aged | Prednisolone - therapeutic use | Antibodies, Anti-Idiotypic - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Mycoses | Index Medicus | Anti-Asthmatic Agents | Anti-Inflammatory Agents | Aspergillosis, Allergic Bronchopulmonary | Life Sciences | Antibodies, Monoclonal, Humanized | Antibodies, Anti-Idiotypic | Prednisolone
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
by Agarwal, Ritesh and Aggarwal, Ashutosh N and Dhooria, Sahajal and Sehgal, Inderpaul Singh and Garg, Mandeep and Saikia, Biman and Behera, Digambar and Chakrabarti, Arunaloke
European Respiratory Journal, ISSN 0903-1936, 02/2016, Volume 47, Issue 2, pp. 490 - 498
Whether use of high-dose steroids in acute-stage allergic bronchopulmonary aspergillosis (ABPA) is associated with superior outcomes is not known. Herein, we... 
DIAGNOSIS | MANAGEMENT | PULMONARY ASPERGILLOSIS | NORTH-INDIA | RESPIRATORY SYSTEM | CLASSIFICATION | ITRACONAZOLE | FUMIGATUS | CLINICAL-SIGNIFICANCE | Glucocorticoids - administration & dosage | Prednisolone - administration & dosage | Humans | Aspergillosis, Allergic Bronchopulmonary - complications | Aspergillosis, Allergic Bronchopulmonary - physiopathology | Male | Tomography, X-Ray Computed | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Forced Expiratory Volume | Young Adult | Bronchiectasis - diagnostic imaging | Adult | Female | Aspergillosis, Allergic Bronchopulmonary - diagnostic imaging | Severity of Illness Index | Acute Disease | Bronchiectasis - drug therapy | Asthma - physiopathology | Treatment Outcome | Asthma - diagnostic imaging | Asthma - drug therapy | Disease Progression | Vital Capacity | Bronchiectasis - complications | Asthma - complications | Bronchiectasis - physiopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Treating allergic bronchopulmonary aspergillosis: The way forward
by Moss, Richard B
European Respiratory Journal, ISSN 0903-1936, 02/2016, Volume 47, Issue 2, pp. 385 - 387
OMALIZUMAB | THERAPY | EFFICACY | RESPIRATORY SYSTEM | FUNGAL ASTHMA | AMPHOTERICIN | CLASSIFICATION | CYSTIC-FIBROSIS | ITRACONAZOLE | INDIA | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Asthma - drug therapy | Humans | Antifungal Agents - therapeutic use | Aspergillosis - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text High-frequency Triazole Resistance Found in Nonculturable Aspergillus fumigatus from Lungs of Patients With Chronic Fungal Disease
by David W. Denning and Steven Park and Cornelia Lass-Florl and Marcin G. Fraczek and Marie Kirwan and Robin Gore and Jaclyn Smith and Ahmed Bueid and Caroline B. Moore and Paul Bowyer and David S. Perlin
Clinical Infectious Diseases, ISSN 1058-4838, 5/2011, Volume 52, Issue 9, pp. 1123 - 1129
Background. Oral triazole therapy is well established for the treatment of invasive (IPA), allergic (ABPA), and chronic pulmonary (CPA) aspergillosis and is... 
Polymerase chain reaction | Antifungals | Aspergillus | Azoles | Triazoles | Aspergillosis | Sputum | ARTICLES AND COMMENTARIES | Allergic bronchopulmonary aspergillosis | Aspergillus fumigatus | Genetic mutation | DIAGNOSIS | INFECTIOUS DISEASES | SEVERE ASTHMA | METAANALYSIS | MICROBIOLOGY | ITRACONAZOLE | IMMUNOLOGY | INVASIVE ASPERGILLOSIS | PULMONARY ASPERGILLOSIS | SENSITIZATION | AZOLE RESISTANCE | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | PCR | Aspergillus fumigatus - drug effects | Sputum - microbiology | Lung - microbiology | Aspergillosis, Allergic Bronchopulmonary - microbiology | Humans | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Antifungal Agents - therapeutic use | Bronchoalveolar Lavage Fluid - microbiology | Aspergillus fumigatus - isolation & purification | Culture Media | Polymerase Chain Reaction | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Invasive Pulmonary Aspergillosis - epidemiology | Triazoles - therapeutic use | Antifungal Agents - pharmacology | Invasive Pulmonary Aspergillosis - drug therapy | Pulmonary Aspergillosis - drug therapy | DNA, Fungal - analysis | Drug Resistance, Fungal - genetics | Aspergillus fumigatus - genetics | Pulmonary Aspergillosis - microbiology | Triazoles - pharmacology | Pulmonary Aspergillosis - epidemiology | Invasive Pulmonary Aspergillosis - microbiology | Mutation | Chronic Disease | Drug resistance in microorganisms | Usage | Physiological aspects | Causes of | Lung diseases, Fungal | Research | Drug therapy | Health aspects | Fungi | Infectious diseases | Medical diagnosis | Deoxyribonucleic acid--DNA | Nonnative species | Polymorphism | Index Medicus | and Commentaries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients
by Becker, K.L and Gresnigt, M.S and Smeekens, S.P and Jacobs, C.W.M and Magis-Escurra Ibanez, C and Jaeger, M and Wang, X and Lubbers, R and Oosting, M and Joosten, L.A.B and Netea, M.G and Reijers, M.H.E and Veerdonk, F.L. van de
Clinical and Experimental Allergy, ISSN 0954-7894, 2015, Volume 45, Issue 2, pp. 423 - 437
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is characterised by an exaggerated Th2 response to Aspergillus fumigatus, but the immunological... 
spergillus fumigatus | allergic bronchopulmonary aspergillosis | interferon‐γ | interleukin‐13 | interleukin‐5 | Aspergillus fumigatus | Allergic bronchopulmonary aspergillosis | Interferon-γ | Interleukin-5 | Interleukin-13 | DENDRITIC CELLS | EOSINOPHILS | NASAL POLYPS | IMMUNOLOGY | interleukin-13 | OSTEOPONTIN EXPRESSION | interleukin-5 | CHRONIC RHINOSINUSITIS | EPITHELIUM | ALLERGY | INFLAMMATION | DISEASE | ASTHMA | interferon-gamma | PROGRESSION | T-Lymphocyte Subsets - immunology | Leukocytes, Mononuclear - metabolism | Humans | Middle Aged | Male | Th2 Cells - immunology | Lectins, C-Type - genetics | Th1 Cells - immunology | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Th2 Cells - drug effects | Case-Control Studies | Th1 Cells - metabolism | Young Adult | Receptors, Pattern Recognition - antagonists & inhibitors | Receptors, Pattern Recognition - metabolism | Immunoglobulin E - immunology | Immunoglobulin G - immunology | T-Lymphocyte Subsets - drug effects | Leukocytes, Mononuclear - immunology | Adult | Female | Macrophage-1 Antigen - metabolism | Aspergillosis, Allergic Bronchopulmonary - metabolism | Aspergillus - immunology | Leukocytes, Mononuclear - drug effects | Cytokines - metabolism | Signal Transduction | Phagocytosis - immunology | Aspergillosis, Allergic Bronchopulmonary - genetics | Antibodies, Fungal - immunology | Th2 Cells - metabolism | T-Lymphocyte Subsets - metabolism | Aspergillosis, Allergic Bronchopulmonary - immunology | Ligands | Aged | Mutation | Cytokines - pharmacology | Bacteria | Corticosteroids | Cytokines | Pulmonary aspergillosis | Biological response modifiers | Enzyme-linked immunosorbent assay | Gram-positive bacteria | Medical research | Pattern recognition | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Serologic allergic bronchopulmonary aspergillosis (ABPA-S): Long-term outcomes
by Agarwal, Ritesh and Garg, Mandeep and Aggarwal, Ashutosh N and Saikia, Biman and Gupta, Dheeraj and Chakrabarti, Arunaloke
Respiratory Medicine, ISSN 0954-6111, 2012, Volume 106, Issue 7, pp. 942 - 947
Summary Background and aim ABPA is radiologically classified on the presence or absence of central bronchiectasis (CB) as ABPA-CB and serologic ABPA (ABPA-S)... 
Pulmonary/Respiratory | Bronchiectasis | Glucocorticoids | ABPA | Allergic bronchopulmonary aspergillosis | Aspergillus fumigatus | Asthma | CARDIAC & CARDIOVASCULAR SYSTEMS | PULMONARY ASPERGILLOSIS | RESPIRATORY SYSTEM | CLINICAL-SIGNIFICANCE | Recurrence | Glucocorticoids - therapeutic use | Asthma - physiopathology | Forced Expiratory Volume - physiology | Humans | Aspergillosis, Allergic Bronchopulmonary - complications | Aspergillosis, Allergic Bronchopulmonary - physiopathology | Male | Tomography, X-Ray Computed | Treatment Outcome | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Immunoglobulin E - blood | Antigens, Fungal - blood | Asthma - complications | Aspergillus fumigatus - immunology | Vital Capacity - physiology | Bronchiectasis - prevention & control | Physical Examination | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Mycoses | Drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
by Emiralioglu, Nagehan and Dogru, Deniz and Tugcu, Gokcen Dilsa and Yalcin, Ebru and Kiper, Nural and Ozcelik, Ugur
Annals of Pharmacotherapy, ISSN 1060-0280, 3/2016, Volume 50, Issue 3, pp. 188 - 193
Background: Allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) is characterized by destructive changes in the airways. Long-term treatment... 
Aspergillus | omalizumab | ABPA | cystic fibrosis | MANAGEMENT | PHARMACOLOGY & PHARMACY | ANTI-IGE ANTIBODY | Humans | Aspergillosis, Allergic Bronchopulmonary - complications | Male | Cystic Fibrosis - complications | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Itraconazole - therapeutic use | Young Adult | Adolescent | Adult | Female | Omalizumab - therapeutic use | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Child | Cystic Fibrosis - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole
by Pierre-Régis Burgel and Marie-Thérèse Baixench and Michaël Amsellem and Etienne Audureau and Jeanne Chapron and Reem Kanaan and Isabelle Honoré and Jean Dupouy-Camet and Daniel Dusser and Corné H. Klaassen and Jacques F. Meis and Dominique Hubert and André Paugam
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2012, Volume 56, Issue 2, pp. 869 - 874
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
LUNG-TRANSPLANT PATIENTS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | IDENTIFICATION | NETHERLANDS | FILAMENTOUS FUNGI | Aspergillus fumigatus - drug effects | Sputum - microbiology | Prevalence | Aspergillosis, Allergic Bronchopulmonary - microbiology | Humans | Aspergillosis, Allergic Bronchopulmonary - complications | Male | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Itraconazole - pharmacology | Young Adult | Aspergillus fumigatus - isolation & purification | Adult | Female | Drug Resistance, Fungal | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Antifungal Agents - pharmacology | Cystic Fibrosis - microbiology | Aspergillus fumigatus - genetics | Azoles - pharmacology | Cystic Fibrosis - complications | Cystic Fibrosis - epidemiology | Itraconazole - therapeutic use | Microbial Sensitivity Tests - methods | Cystic Fibrosis - drug therapy | Cohort Studies | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
by Agarwal, R and Dhooria, S and Sehgal, IS and Aggarwal, AN and Garg, M and Saikia, B and Chakrabarti, A
EUROPEAN RESPIRATORY JOURNAL, ISSN 0903-1936, 09/2018, Volume 52, Issue 3
DIAGNOSIS | RESPIRATORY SYSTEM | ITRACONAZOLE | Prednisolone - adverse effects | Antifungal Agents - adverse effects | Prednisolone - administration & dosage | Voriconazole - adverse effects | Humans | Middle Aged | Male | Treatment Outcome | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Immunoglobulin E - blood | Young Adult | Voriconazole - administration & dosage | Asthma - complications | Adult | Female | Antifungal Agents - administration & dosage
Journal Article
Details down arrow
12. Full Text Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma
by O'Driscoll, B. R and Powell, G and Chew, F and Niven, R. M and Miles, J. F and Vyas, A and Denning, D. W
Clinical & Experimental Allergy, ISSN 0954-7894, 11/2009, Volume 39, Issue 11, pp. 1677 - 1683
Summary Background It has been shown that patients with allergic bronchopulmonary aspergillosis (ABPA) and patients with severe asthma with fungal... 
allergy | specific serum IgE test | asthma | skin prick test | fungal sensitization | Skin prick test | Allergy | Specific serum ige test | Fungal sensitization | Asthma | FOOD ALLERGY | SENSITIVITY | ITRACONAZOLE | IMMUNOLOGY | CHILDREN | TRIAL | RAST | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | Severity of Illness Index | Skin Tests | Humans | Middle Aged | Male | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Asthma - drug therapy | Immunoglobulin E - blood | Fungi | Immunoglobulin E - immunology | Aspergillosis, Allergic Bronchopulmonary - immunology | Asthma - blood | Adolescent | Aspergillosis, Allergic Bronchopulmonary - blood | Asthma - immunology | Adult | Female | Aged | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Asthma - epidemiology | Care and treatment | Antifungal agents | Mycoses | Immunoglobulin E | Medical tests | Diagnosis | Comparative analysis | Hypersensitivity | Thorax | Allergic bronchopulmonary aspergillosis | Skin tests | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis
by Stevens, David A and Schwartz, Howard J and Lee, Jeannette Y and Moskovitz, Bruce L and Jerome, Dennis C and Catanzaro, Antonino and Bamberger, David M and Weinmann, Allison J and Tuazon, Carmelita U and Judson, Marc A and Platts-Mills, Thomas A.E and Grossman, Jay and Slavin, Raymond G and Reuman, Peter and DeGraff, Arthur C
The New England Journal of Medicine, ISSN 0028-4793, 03/2000, Volume 342, Issue 11, pp. 756 - 762
Allergic bronchopulmonary aspergillosis is a hypersensitivity disease of the lungs that is almost always caused by Aspergillus fumigatus (Table 1). Several... 
CRITERIA | MEDICINE, GENERAL & INTERNAL | INVASIVE ASPERGILLOSIS | THERAPY | INVITRO | KETOCONAZOLE | FLUCONAZOLE | Antifungal Agents - adverse effects | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Adrenal Cortex Hormones - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Immunoglobulin E - blood | Antifungal Agents - therapeutic use | Itraconazole - therapeutic use | Itraconazole - adverse effects | Aspergillosis, Allergic Bronchopulmonary - immunology | Female | Drug Therapy, Combination | Evaluation | Drug therapy | Aspergillosis | Itraconazole | Studies | Disease | Cystic fibrosis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights